Exercise therapy in Type 2 diabetes
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Structured exercise is considered an important cornerstone to achieve good glycemic control and improve cardiovascular risk profile in Type 2 diabetes. Current clinical guidelines acknowledge the therapeutic strength of exercise intervention. This paper reviews the wide pathophysiological problems associated with Type 2 diabetes and discusses the benefits of exercise therapy on phenotype characteristics, glycemic control and cardiovascular risk profile in Type 2 diabetes patients. Based on the currently available literature, it is concluded that Type 2 diabetes patients should be stimulated to participate in specifically designed exercise intervention programs. More attention should be paid to cardiovascular and musculoskeletal deconditioning as well as motivational factors to improve long-term treatment adherence and clinical efficacy. More clinical research is warranted to establish the efficacy of exercise intervention in a more differentiated approach for Type 2 diabetes subpopulations within different stages of the disease and various levels of co-morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“study [23, 46].”
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“Although the combination of intense blood pressure and blood glucose lowering therapy has been shown to reduce (microvascular) complications [129–131], stringent application of multiple blood glucose lowering drugs does not necessarily result in a further reduction of macrovascular events [130, 132–135].”
BackgroundEffect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675 · cited 1×
“Although the combination of intense blood pressure and blood glucose lowering therapy has been shown to reduce (microvascular) complications [129–131], stringent application of multiple blood glucose lowering drugs does not necessarily result in a further reduction of macrovascular events [130, 132–135].”
BackgroundHASKELL, W. L., LEE, I.-M., PATE, R. R., POWELL, K. E., BLAIR, S. N., FRANKLIN, B. A., MACERA, C. A., HEATH, G. W., THOMPSON, P. D., & BAUMAN, A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3180616b27 · Cited by 4,616
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843 · cited 1×
“polymorphisms (SNPs) related to beta-cell function predispose to the development of Type 2 diabetes [8–11], clinical characteristics such as obesity and lack of physical”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388 · cited 1×
“status [143].”
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · cited 1×
“Chronic exposure to Amadori products, AGE and ROS, so-called glucolipotoxicity, can cause vasculopathy [76], glomerulopathy [79, 80] and potentially also induce nerve cell damage [81].”
BackgroundLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“Ectopic fat storage in hepatocytes, so-called intrahepatic lipids (IHL), has also been related to the development of hepatic insulin resistance [72] and hepatic inflammation, initiating non-alcoholic fatty liver disease [73].”
BackgroundOxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“Whether this lower oxygen uptake capacity is attributed to a low habitual physical activity level, reduced mitochondrial content or an intrinsic mitochondrial defect is a topic of intense debate [96–109].”
BackgroundSerum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · cited 1×
“Although results of long-term intervention studies are underway, the current increase in Type 2 diabetes incidence and concomitant cardiovascular co-morbidities may benefit more from therapeutic strategies entailing structured exercise interventions with [136–138] or without [137, 139, 140] dietary modulation and/or o…”
BackgroundRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522 · cited 3×
“Although fasting blood lipid profiles in Type 2 diabetes populations have been shown to improve following longterm exercise interventions with [136, 137, 155] or without dietary restriction [142, 156], recent exercise intervention”
BackgroundMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“In rodents, 3 days of a high-fat diet induces hepatic insulin resistance, while no significant changes in fat content in muscle or visceral tissue could be detected [74].”
BackgroundRetinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · cited 1×
“More recently, a new adipokine, named retinol binding protein-4, has been discovered that is directly linked to the level of obesity-induced insulin resistance, both in crosssectional [54, 55] and longitudinal studies [54, 56–58].”
BackgroundThe UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084 · cited 1×
“uk) may be of help to calculate an individual patient’s risk for coronary heart disease [251].”
BackgroundExercise, Glucose Transport, and Insulin Sensitivity
Goodyear, L. J., & Kahn, B. B. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.235 · Cited by 1,056
Physical Activity/Exercise and Type 2 Diabetes
Sigal, R. J., Kenny, G. P., Wasserman, D. H., Castaneda-Sceppa, C., & White, R. D. (2006) · Diabetes Care · doi:10.2337/dc06-9910 · Cited by 949
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945 · cited 1×
“It has been suggested that these hyperglycemic blood glucose excursions may contribute to the development of macro- and/or microvascular complications in prediabetic states [21, 22].”
BackgroundPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 1×
“Both aggravate insulin resistance in skeletal muscle [47, 48] and the liver [49, 50].”
BackgroundGlucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897 · cited 1×
“Once the beta-cell fails, post-prandial hyperglycemia may induce large amounts of reactive oxygen species (ROS) that can cause further damage to cellular components of insulin production and induce apoptosis in beta-cells [27].”
BackgroundSkyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Diabetes, Obesity, and the Brain
Schwartz, M. W., & Porte, D. (2005) · Science · doi:10.1126/science.1104344 · Cited by 841
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“In addition, intra-cellular lipid metabolites such as diacylglycerol (DAG), long chain fatty-acyl CoA and ceramides have been shown to interfere with the insulin signaling pathway [70].”
BackgroundSnowling, N. J., & Hopkins, W. G. (2006) · Diabetes Care · doi:10.2337/dc06-1317 · Cited by 813
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
Wackers, F. J. T., Young, L. H., Inzucchi, S. E., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Wittlin, S. D., Heller, G. V., Filipchuk, N., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1954 · Cited by 791 · cited 6×
“Cardiac dysfunction [246] and SMI are estimated to be present between 6 and 22% [247] of the Type 2 diabetes patients, with cardiac autonomic dysfunction, disease duration and male gender being the best predictors for SMI [247].”
BackgroundInfluentialExercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790
The Look AHEAD Research Group (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00064-3 · Cited by 767 · cited 2×
“, the ‘BeweegKuur’ in the Netherlands [265] and the LookAHEAD study in the USA) [271] are underway.”
BackgroundExercise for type 2 diabetes mellitus
Thomas, D., Elliott, E. J., & Naughton, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002968.pub2 · Cited by 728
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699 · cited 1×
“Prolonged endurancetype exercise training has been shown to improve insulin sensitivity in both young [190], elderly [191] and/or insulin-resistant subjects [178, 192–194].”
BackgroundMiller, W., Koceja, D., & Hamilton, E. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800499 · Cited by 686 · cited 1×
“The latter may be related to the lack of a simultaneously diet-induced weight loss [158], a compensatory decline in daily physical activity level [159] or the fact that in most Type 2 diabetes populations baseline total-cholesterol, LDL-cholesterol and triglycerides levels were”
BackgroundHolten, M. K., Zacho, M., Gaster, M., Juel, C., Wojtaszewski, J. F. P., & Dela, F. (2004) · Diabetes · doi:10.2337/diabetes.53.2.294 · Cited by 615
Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573
Cavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569
Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519
Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Larson-Meyer, D. E., Heilbronn, L. K., Redman, L. M., Newcomer, B. R., Frisard, M. I., Anton, S., Smith, S. R., Alfonso, A., Ravussin, E., & the Pennington CALERIE Team (2006) · Diabetes Care · doi:10.2337/dc05-2565 · Cited by 504
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“Experimental research now suggests that hepatic insulin resistance arises from DAG-induced activation of protein kinase Ce, which directly binds to and inhibits insulin receptor tyrosine kinase activity [75].”
BackgroundHypoglycaemia in Type 2 diabetes
Amiel, S. A., Dixon, T., Mann, R., & Jameson, K. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02341.x · Cited by 472
Gerritsen, J., Dekker, J. M., TenVoorde, B. J., Kostense, P. J., Heine, R. J., Bouter, L. M., Heethaar, R. M., & Stehouwer, C. D. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1793 · Cited by 456 · cited 1×
“Because potentiation of atherogenesis and cardiac dysfunction occurs in the presence of early diabetic symptoms as well as in the established disease [122, 123], early implementation of strategies to reduce cardiovascular risk factors and to attenuate diabetes progression may help to improve long-term outcomes for at-…”
BackgroundSimoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441
Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · cited 1×
“Ectopic fat storage in hepatocytes, so-called intrahepatic lipids (IHL), has also been related to the development of hepatic insulin resistance [72] and hepatic inflammation, initiating non-alcoholic fatty liver disease [73].”
BackgroundDiverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411
Mattusch, Dufaux, Heine, Mertens, & Rost (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-8852 · Cited by 389
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Type 2 Diabetes, Muscle Strength, and Impaired Physical Function
Sayer, A. A., Dennison, E. M., Syddall, H. E., Gilbody, H. J., Phillips, D. I. W., & Cooper, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2541 · Cited by 366
Moretto, T. J., Milton, D. R., Ridge, T. D., MacConell, L. A., Okerson, T., Wolka, A. M., & Brodows, R. G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.08.006 · Cited by 350 · cited 1×
“Nevertheless, more long-term efficacy of incretin mimicking drugs should be awaited before their clinical value as a mono- or add-on therapy can be established [37–39].”
BackgroundThe anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control
Pedersen, B. K. (2006) · Essays in Biochemistry · doi:10.1042/bse0420105 · Cited by 349
Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
Boden, G., & Chen, X. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118160 · Cited by 344
Enhanced Peripheral and Splanchnic Insulin Sensitivity in NIDDM Men After Single Bout of Exercise
Devlin, J. T., Hirshman, M., Horton, E. D., & Horton, E. S. (1987) · Diabetes · doi:10.2337/diab.36.4.434 · Cited by 342
Tudor-Locke, C., Bell, R. C., Myers, A. M., Harris, S. B., Ecclestone, N. A., Lauzon, N., & Rodger, N. W. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802485 · Cited by 321
Habitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans
Perseghin, G., Lattuada, G., De Cobelli, F., Ragogna, F., Ntali, G., Esposito, A., Belloni, E., Canu, T., Terruzzi, I., Scifo, P., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2032 · Cited by 320
Effect of Acute Exercise on AMPK Signaling in Skeletal Muscle of Subjects with Type 2 Diabetes
Sriwijitkamol, A., Coletta, D. K., Wajcberg, E., Balbontin, G. B., Reyna, S. M., Barrientes, J., Eagan, P. A., Jenkinson, C. P., Cersosimo, E., DeFronzo, R. A., et al. (2007) · Diabetes · doi:10.2337/db06-1119 · Cited by 304
Schrauwen-Hinderling, V. B., Kooi, M. E., Hesselink, M. K. C., Jeneson, J. A. L., Backes, W. H., van Echteld, C. J. A., van Engelshoven, J. M. A., Mensink, M., & Schrauwen, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0475-1 · Cited by 304 · cited 1×
“Whether this lower oxygen uptake capacity is attributed to a low habitual physical activity level, reduced mitochondrial content or an intrinsic mitochondrial defect is a topic of intense debate [96–109].”
BackgroundThe Influence of Exercise Training on Inflammatory Cytokines and C-Reactive Protein
STEWART, L. K., FLYNN, M. G., CAMPBELL, W. W., CRAIG, B. A., ROBINSON, J. P., TIMMERMAN, K. L., MCFARLIN, B. K., COEN, P. M., & TALBERT, E. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31811ece1c · Cited by 283
Lambert, C. P., Wright, N. R., Finck, B. N., & Villareal, D. T. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00006.2008 · Cited by 249
Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · cited 1×
“Whether this lower oxygen uptake capacity is attributed to a low habitual physical activity level, reduced mitochondrial content or an intrinsic mitochondrial defect is a topic of intense debate [96–109].”
BackgroundIncreased intramuscular lipid storage in the insulin-resistant and endurance-trained state
van Loon, L. J. C., & Goodpaster, B. H. (2006) · Pflügers Archiv · doi:10.1007/s00424-005-1509-0 · Cited by 232
Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
Holst, J. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0107-1 · Cited by 228
Koopman, R., Zorenc, A. H. G., Gransier, R. J. J., Cameron-Smith, D., & van Loon, L. J. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00530.2005 · Cited by 196 · cited 1×
“On the other hand, resistance-type exercise is able to induce muscle protein synthesis [186, 187] and, as such, represents an effective interventional strategy to increase lean body mass in both early [188] and advanced stage Type 2 diabetes patients [146, 189].”
BackgroundDunstan, D. W., Daly, R. M., Owen, N., Jolley, D., Vulikh, E., Shaw, J., & Zimmet, P. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.3 · Cited by 194
The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients
Larsen, J. J. S., Dela, F., Kjær, M., & Galbo, H. (1997) · Diabetologia · doi:10.1007/s001250050699 · Cited by 183 · cited 1×
“Several studies have shown that the energy equivalent of an endurance exercise bout represents the major determinant of the exercise-induced changes in glucose homeostasis [200–202].”
BackgroundLow-Intensity Exercise Reduces the Prevalence of Hyperglycemia in Type 2 Diabetes
MANDERS, R. J. F., VAN DIJK, J.-W. M., & VAN LOON, L. J. C. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b3b16d · Cited by 180
Russell, A. P., Gastaldi, G., Bobbioni-Harsch, E., Arboit, P., Gobelet, C., Dériaz, O., Golay, A., Witztum, J. L., & Giacobino, J.-P. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00875-5 · Cited by 166 · cited 1×
“Indeed, not IMCL content itself, but rather the peroxidation of inactive pools of IMCL and intra-cellular fatty acids may explain the apparent correlation between IMCL content and insulin resistance [69].”
BackgroundRosenstock, J., Foley, J. E., Rendell, M., Landin-Olsson, M., Holst, J. J., Deacon, C. F., Rochotte, E., & Baron, M. A. (2008) · Diabetes Care · doi:10.2337/dc07-1616 · Cited by 153
MacIntyre, P., Fisher, M., Kirk, A., & Mutrie, N. (2004) · Diabetologia · doi:10.1007/s00125-004-1396-5 · Cited by 139
Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk
Jacobs-van der Bruggen, M. A. M., Bos, G., Bemelmans, W. J., Hoogenveen, R. T., Vijgen, S. M., & Baan, C. A. (2007) · Diabetes Care · doi:10.2337/dc06-0690 · Cited by 137
Henriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.04.002 · Cited by 136 · cited 1×
“prevent diabetes-related complications [92].”
Howorka, K. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00040-0 · Cited by 133
Balducci, S., Leonetti, F., Di Mario, U., & Fallucca, F. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.841 · Cited by 131
Fowler-Brown, A., Pignone, M., Pletcher, M., Tice, J. A., Sutton, S. F., & Lohr, K. N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-w1 · Cited by 122
Exercise and Glycemic Control in Diabetes: Benefits, Challenges, and Adjustments to Pharmacotherapy
Gulve, E. A. (2008) · Physical Therapy · doi:10.2522/ptj.20080114 · Cited by 120
De Feyter, H. M., van den Broek, N. M. A., Praet, S. F. E., Nicolay, K., van Loon, L. J. C., & Prompers, J. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0756 · Cited by 116 · cited 2×
“Recent experimental evidence indicates that mitochondrial respiration is not abnormal when normalized for mitochondrial content [104, 110], which implies that low habitual physical activity level and/or cardiovascular dysfunction may explain the generally deconditioned state in the Type 2 diabetes patient [97, 106].”
BackgroundThe effect of intense exercise on postprandial glucose homeostasis in type II diabetic patients
Larsen, J. J. S., Dela, F., Madsbad, S., & Galbo, H. (1999) · Diabetologia · doi:10.1007/s001250051440 · Cited by 112 · cited 1×
“Proc Natl Acad Sci U S A 2003;100(14):8466-71.”
The Effects of Exercise Training on Fat-Mass Loss in Obese Patients During Energy Intake Restriction
Hansen, D., Dendale, P., Berger, J., van Loon, L. J. C., & Meeusen, R. (2007) · Sports Medicine · doi:10.2165/00007256-200737010-00003 · Cited by 106 · cited 1×
“less, in accordance with earlier reports (for references see [160]), detailed body composition analyses using dual energy X-ray absorptiometry (DEXA) and MRI revealed”
ResultDavis, S. N., Mann, S., Galassetti, P., Neill, R. A., Tate, D., Ertl, A. C., & Costa, F. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1897 · Cited by 100 · cited 1×
“In accordance with Type 1 diabetes patients [221, 222], antecedent hypoglycemia may also result in hypoglycemia unawareness in Type 2 diabetes [223] However, circumstances that result in inappropriate elevations in blood glucose levels (such as excessive carbohydrate supplementation or too large reductions in insulin…”
BackgroundD'Alessio, D. A., Denney, A. M., Hermiller, L. M., Prigeon, R. L., Martin, J. M., Tharp, W. G., Saylan, M. L., He, Y., Dunning, B. E., Foley, J. E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1135 · Cited by 99 · cited 1×
“These incretin mimicking drugs have been shown to improve islet-cell function, and both fasting and post-prandial glycemic control [32–36].”
BackgroundPrevention of glycogen supercompensation prolongs the increase in muscle GLUT4 after exercise
Garcia-Roves, P. M., Han, D.-H., Song, Z., Jones, T. E., Hucker, K. A., & Holloszy, J. O. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00216.2003 · Cited by 93
Influence of acute exercise on hyperglycemia in insulin-treated type 2 diabetes
PRAET, S. F., MANDERS, R. J., LIEVERSE, A. G., KUIPERS, H., STEHOUWER, C. D., KEIZER, H. A., & VAN LOON, L. J. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000235352.09061.1d · Cited by 85
Self-citationPraet, S. F. E., Jonkers, R. A. M., Schep, G., Stehouwer, C. D. A., Kuipers, H., Keizer, H. A., & van Loon, L. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0169 · Cited by 80
Self-citationDavis, S. N., Mann, S., Briscoe, V. J., Ertl, A. C., & Tate, D. B. (2009) · Diabetes · doi:10.2337/db08-1230 · Cited by 74
Trenell, M. I., Hollingsworth, K. G., Lim, E. L., & Taylor, R. (2008) · Diabetes Care · doi:10.2337/dc08-0303 · Cited by 71 · cited 1×
“Whether this lower oxygen uptake capacity is attributed to a low habitual physical activity level, reduced mitochondrial content or an intrinsic mitochondrial defect is a topic of intense debate [96–109].”
BackgroundExercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes
McAuley, P. A., Myers, J. N., Abella, J. P., Tan, S. Y., & Froelicher, V. F. (2007) · Diabetes Care · doi:10.2337/dc06-2397 · Cited by 69
Interaction of sulfonylureas and exercise on glucose homeostasis in type 2 diabetic patients
Larsen, J. J., Dela, F., Madsbad, S., Vibe-Petersen, J., & Galbo, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.10.1647 · Cited by 62
Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes
(2004) · New England Journal of Medicine · doi:10.1056/nejm200406033502320 · Cited by 59
Bisquolo, V. A. F., Cardoso, C. G., Ortega, K. C., Gusmão, J. L., Tinucci, T., Negrão, C. E., Wajchenberg, B. L., Mion, D., & Forjaz, C. L. M. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00251.2004 · Cited by 54 · cited 1×
“cle glycogen stores [174, 176–178], and/or increased skeletal muscle blood flow following the cessation of exercise [179].”
BackgroundDe Feyter, H. M., Praet, S. F., van den Broek, N. M., Kuipers, H., Stehouwer, C. D., Nicolay, K., Prompers, J. J., & van Loon, L. J. C. (2007) · Diabetes Care · doi:10.2337/dc07-0183 · Cited by 51
Self-citationTHE AGE-INCIDENCE RELATIONS IN DIABETES MELLITUS
PINCUS, G., JOSLIN, E. P., & WHITE, P. (1934) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193407000-00015 · Cited by 14
Cited by
Adherence to Therapies in Patients with Type 2 Diabetes
García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013) · Diabetes Therapy · doi:10.1007/s13300-013-0034-y · Cited by 726
Jorge, M. L. M. P., de Oliveira, V. N., Resende, N. M., Paraiso, L. F., Calixto, A., Diniz, A. L. D., Resende, E. S., Ropelle, E. R., Carvalheira, J. B., Espindola, F. S., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.01.006 · Cited by 398
Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes
Bweir, S., Al-Jarrah, M., Almalty, A.-M., Maayah, M., Smirnova, I. V., Novikova, L., & Stehno-Bittel, L. (2009) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-1-27 · Cited by 117
Resistance Training and Older Adults with Type 2 Diabetes Mellitus: Strength of the Evidence
Hovanec, N., Sawant, A., Overend, T. J., Petrella, R. J., & Vandervoort, A. A. (2012) · Journal of Aging Research · doi:10.1155/2012/284635 · Cited by 79
Helmink, J. H., Meis, J. J., de Weerdt, I., Visser, F. N., de Vries, N. K., & Kremers, S. P. (2010) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-7-49 · Cited by 64
Metadata
- Authors
- Praet, S. F. E., & van Loon, L. J. C.
- Venue
- Acta Diabetologica
- Published
- 2009-05-29
- Volume
- 46
- Issue
- 4
- Pages
- 263-278
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W2099795854
- Cited by
- 128
- References
- 106
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.